{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:35:31Z","timestamp":1791830131647,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602137"],"award-info":[{"award-number":["81602137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871951"],"award-info":[{"award-number":["81871951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602137"],"award-info":[{"award-number":["81602137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572392"],"award-info":[{"award-number":["81572392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018B030306049"],"award-info":[{"award-number":["2018B030306049"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313485"],"award-info":[{"award-number":["2017A030313485"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030312015"],"award-info":[{"award-number":["2014A030312015"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastric cancer (GC) is one of the most common malignancies worldwide. Due to the low rate of early detection, most GC patients were diagnosed as advance stages and had poor response to chemotherapy. Some studies found that Fumarate hydratase (FH) participated in the DNA damage response and its deficiency was associated with tumorigenesis in some cancers. In this study, we investigated the relationship between FH and cisplatin (CDDP) sensitivity in GC cell lines. We found that FH was the most significant gene which induced by CDDP treatment and the suppression of FH could enhance the cytotoxicity of CDDP. Miconazole Nitrate (MN) could inhibit FH activity and enhance the effect of CDDP in vitro and in vivo. We also investigated the significance of expression of FH in GC tissues. The FH expression, which was higher in GC tissues than in noncancerous tissues, was negatively associated with the prognosis of patients. Together, these results revealed that FH is a reliable indicator for response to CDDP treatment in GC and the inhibition of FH may be a potential strategy to improve the effects of CDDP-based chemotherapy.<\/jats:p>","DOI":"10.1038\/s41419-019-1652-8","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:03:18Z","timestamp":1559044998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["RETRACTED ARTICLE: Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Hong-En","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-5625","authenticated-orcid":false,"given":"Zhao-Lei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-6235","authenticated-orcid":false,"given":"Miao-Zhen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Ying","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Bang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Qiang","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-8534","authenticated-orcid":false,"given":"Rui-Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"1652_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394\u2013424 (2018).","journal-title":"CA Cancer J Clin"},{"key":"1652_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev 25, 16\u201327 (2016).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1652_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1470-2045(17)30043-8","volume":"18","author":"D Cunningham","year":"2017","unstructured":"Cunningham, D. et al. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial. Lancet Oncol 18, 357\u2013370 (2017).","journal-title":"Lancet Oncol"},{"key":"1652_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10147-007-0750-2","volume":"13","author":"T Mizoshita","year":"2008","unstructured":"Mizoshita, T. et al. Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil. Int J Clin Oncol 13, 373\u2013376 (2008).","journal-title":"Int J Clin Oncol"},{"key":"1652_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/annonc\/mdn717","volume":"20","author":"YK Kang","year":"2009","unstructured":"Kang, Y. K. et al. Capecitabine\/cisplatin versus 5-fluorouracil\/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol 20, 666\u2013673 (2009).","journal-title":"Ann Oncol"},{"key":"1652_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000086773","volume":"68","author":"JG Kim","year":"2005","unstructured":"Kim, J. G. et al. Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer. Oncology 68, 190\u2013195 (2005).","journal-title":"Oncology"},{"key":"1652_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl005","volume":"17","author":"KF Giordano","year":"2006","unstructured":"Giordano, K. F. et al. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 17, 652\u2013656 (2006).","journal-title":"Ann Oncol"},{"key":"1652_CR8","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/S0021-9258(19)81652-6","volume":"264","author":"T Suzuki","year":"1989","unstructured":"Suzuki, T., Sato, M., Yoshida, T. & Tuboi, S. Rat liver mitochondrial and cytosolic fumarases with identical amino acid sequences are encoded from a single gene. J Biol Chem 264, 2581\u20132586 (1989).","journal-title":"J Biol Chem"},{"key":"1652_CR9","doi-asserted-by":"publisher","first-page":"12275","DOI":"10.1016\/S0021-9258(18)45347-1","volume":"262","author":"M Wu","year":"1987","unstructured":"Wu, M. & Tzagoloff, A. Mitochondrial and cytoplasmic fumarases in Saccharomyces cerevisiae are encoded by a single nuclear gene FUM1. J Biol Chem 262, 12275\u201312282 (1987).","journal-title":"J Biol Chem"},{"key":"1652_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/bj2370547","volume":"237","author":"SA Woods","year":"1986","unstructured":"Woods, S. A., Miles, J. S., Roberts, R. E. & Guest, J. R. Structural and functional relationships between fumarase and aspartase. Nucleotide sequences of the fumarase (fumC) and aspartase (aspA) genes of Escherichia coli K12. Biochem J 237, 547\u2013557 (1986).","journal-title":"Biochem J"},{"key":"1652_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson, I. P. et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nature genetics 30, 406\u2013410 (2002).","journal-title":"Nature genetics"},{"key":"1652_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/IJNRD.S42097","volume":"7","author":"LS Schmidt","year":"2014","unstructured":"Schmidt, L. S. & Linehan, W. M. Hereditary leiomyomatosis and renal cell carcinoma. International journal of nephrology and renovascular disease 7, 253\u2013260 (2014).","journal-title":"International journal of nephrology and renovascular disease"},{"key":"1652_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/cup.12396","volume":"41","author":"M Llamas-Velasco","year":"2014","unstructured":"Llamas-Velasco, M. et al. Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. Journal of Cutaneous Pathology 41, 859\u2013865 (2014).","journal-title":"Journal of Cutaneous Pathology"},{"key":"1652_CR14","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1111\/j.1742-4658.2011.08359.x","volume":"278","author":"O Yogev","year":"2011","unstructured":"Yogev, O., Naamati, A. & Pines, O. Fumarase: a paradigm of dual targeting and dual localized functions. The FEBS journal 278, 4230\u20134242 (2011).","journal-title":"The FEBS journal"},{"key":"1652_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/tra.12397","volume":"17","author":"E Dik","year":"2016","unstructured":"Dik, E., Naamati, A., Asraf, H., Lehming, N. & Pines, O. Human Fumarate Hydratase Is Dual Localized by an Alternative Transcription Initiation Mechanism. Traffic 17, 720\u2013732 (2016).","journal-title":"Traffic"},{"key":"1652_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000328","volume":"8","author":"O Yogev","year":"2010","unstructured":"Yogev, O. et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic\/nuclear component of the DNA damage response. PLoS biology 8, e1000328 (2010).","journal-title":"PLoS biology"},{"key":"1652_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/ncb3209","volume":"17","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nature cell biology 17, 1158\u20131168 (2015).","journal-title":"Nature cell biology"},{"key":"1652_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1074\/mcp.M800195-MCP200","volume":"8","author":"R Liu","year":"2009","unstructured":"Liu, R. et al. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol Cell Proteomics 8, 70\u201385 (2009).","journal-title":"Mol Cell Proteomics"},{"key":"1652_CR19","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.3892\/or.2017.5608","volume":"37","author":"SY Yuan","year":"2017","unstructured":"Yuan, S. Y. et al. Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells. Oncol Rep 37, 3606\u20133616 (2017).","journal-title":"Oncol Rep"},{"key":"1652_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/taap.2002.9352","volume":"180","author":"CH Wu","year":"2002","unstructured":"Wu, C. H. et al. Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0\/G1 cell cycle arrest. Toxicol Appl Pharmacol 180, 22\u201335 (2002).","journal-title":"Toxicol Appl Pharmacol"},{"key":"1652_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccr.2013.11.011","volume":"25","author":"J Hou","year":"2014","unstructured":"Hou, J. et al. Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma. Cancer Cell 25, 49\u201363 (2014).","journal-title":"Cancer Cell"},{"key":"1652_CR22","first-page":"2877","volume":"126","author":"WY Cai","year":"2013","unstructured":"Cai, W. Y. et al. The Wnt-beta-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion. J Cell Sci 126, 2877\u20132889 (2013).","journal-title":"J Cell Sci"},{"key":"1652_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejphar.2014.04.047","volume":"737","author":"T Zheng","year":"2014","unstructured":"Zheng, T., Wang, X. & Yim, M. Miconazole inhibits receptor activator of nuclear factor-kappaB ligand-mediated osteoclast formation and function. Eur J Pharmacol 737, 185\u2013193 (2014).","journal-title":"Eur J Pharmacol"},{"key":"1652_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2017.10.007","volume":"412","author":"QN Wu","year":"2018","unstructured":"Wu, Q. N. et al. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance. Cancer Lett 412, 243\u2013255 (2018).","journal-title":"Cancer Lett"},{"key":"1652_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2007.08.048","volume":"350","author":"V Barillaro","year":"2008","unstructured":"Barillaro, V. et al. Theoretical and experimental vibrational study of miconazole and its dimers with organic acids: application to the IR characterization of its inclusion complexes with cyclodextrins. Int J Pharm 350, 155\u2013165 (2008).","journal-title":"Int J Pharm"},{"key":"1652_CR26","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/sj.onc.1202925","volume":"18","author":"P Chaturvedi","year":"1999","unstructured":"Chaturvedi, P. et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047\u20134054 (1999).","journal-title":"Oncogene"},{"key":"1652_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","volume":"4","author":"D Wang","year":"2005","unstructured":"Wang, D. & Lippard, S. J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4, 307\u2013320 (2005).","journal-title":"Nat Rev Drug Discov"},{"key":"1652_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bjc.2016.266","volume":"115","author":"SA Bhide","year":"2016","unstructured":"Bhide, S. A. et al. Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. Br J Cancer 115, 825\u2013830 (2016).","journal-title":"Br J Cancer"},{"key":"1652_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","volume":"66","author":"M Goldstein","year":"2015","unstructured":"Goldstein, M. & Kastan, M. B. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med 66, 129\u2013143 (2015).","journal-title":"Annu Rev Med"},{"key":"1652_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/sj.bjc.6601729","volume":"90","author":"H Willers","year":"2004","unstructured":"Willers, H., Dahm-Daphi, J. & Powell, S. N. Repair of radiation damage to DNA. Br J Cancer 90, 1297\u20131301 (2004).","journal-title":"Br J Cancer"},{"key":"1652_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.12.038","volume":"358","author":"H Tian","year":"2015","unstructured":"Tian, H. et al. DNA damage response--a double-edged sword in cancer prevention and cancer therapy. Cancer Lett 358, 8\u201316 (2015).","journal-title":"Cancer Lett"},{"key":"1652_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mrfmmm.2017.07.011","volume":"803\u2013805","author":"A Shibata","year":"2017","unstructured":"Shibata, A. Regulation of repair pathway choice at two-ended DNA double-strand breaks. Mutat Res 803\u2013805, 51\u201355 (2017).","journal-title":"Mutat Res"},{"key":"1652_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/2472555217746324","volume":"23","author":"AL Bredemeyer","year":"2018","unstructured":"Bredemeyer, A. L. et al. High-throughput screening approach for identifying compounds that inhibit nonhomologous end joining. SLAS Discov 23, 624\u2013633 (2018).","journal-title":"SLAS Discov"},{"key":"1652_CR34","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.1074\/jbc.M113.520429","volume":"289","author":"A Inoue","year":"2014","unstructured":"Inoue, A. et al. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin. J Biol Chem 289, 7109\u20137120 (2014).","journal-title":"J Biol Chem"},{"key":"1652_CR35","first-page":"3533","volume":"7","author":"DB Longley","year":"2001","unstructured":"Longley, D. B. et al. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies. Clin Cancer Res 7, 3533\u20133539 (2001).","journal-title":"Clin Cancer Res"},{"key":"1652_CR36","first-page":"10017","volume":"44","author":"WP Roos","year":"2016","unstructured":"Roos, W. P. & Krumm, A. The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair. Nucleic Acids Res 44, 10017\u201310030 (2016).","journal-title":"Nucleic Acids Res"},{"key":"1652_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.molcel.2015.02.024","volume":"58","author":"W Jiang","year":"2015","unstructured":"Jiang, W. et al. Differential phosphorylation of DNA-PKcs regulates the interplay between end-processing and end-ligation during nonhomologous end-joining. Mol Cell 58, 172\u2013185 (2015).","journal-title":"Mol Cell"},{"key":"1652_CR38","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah, L. J., El-Osta, A. & Karagiannis, T. C. GammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24, 679\u2013686 (2010).","journal-title":"Leukemia"},{"key":"1652_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","volume":"9","author":"JJ Tentler","year":"2012","unstructured":"Tentler, J. J. et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9, 338\u2013350 (2012).","journal-title":"Nat Rev Clin Oncol"},{"key":"1652_CR40","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","volume":"18","author":"S Kopetz","year":"2012","unstructured":"Kopetz, S., Lemos, R. & Powis, G. The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res 18, 5160\u20135162 (2012).","journal-title":"Clin Cancer Res"},{"key":"1652_CR41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc.2016.140","volume":"17","author":"AT Byrne","year":"2017","unstructured":"Byrne, A. T. et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer 17, 254\u2013268 (2017).","journal-title":"Nat Rev Cancer"}],"updated-by":[{"DOI":"10.1038\/s41419-023-05604-7","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"record-id":"42140"},{"DOI":"10.1038\/s41419-023-05604-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1652-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:38:44Z","timestamp":1679859524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1652-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["1652"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1652-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-023-05604-7","URL":"https:\/\/doi.org\/10.1038\/s41419-023-05604-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"413"}}